Labiana S.A. Logo

Labiana S.A.

Pharmaceutical CDMO for animal & human health with its own line of vaccines and generics.

LAB | MC

Overview

Corporate Details

ISIN(s):
ES0105638003
LEI:
959800PSH8S68MKGZF50
Country:
Spain
Address:
CALLE EUROPA 34 1D, 28023 Pozuelo de Alarcón
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Labiana S.A. is an international pharmaceutical group specializing in both animal and human health, with a history dating back to 1958. The company's operations are centered on two main pillars: contract development and manufacturing (CDMO) services for third parties and the development and commercialization of its own-branded products. As a CDMO, Labiana offers high-quality, flexible manufacturing services, with a specialization in sterile forms. Its proprietary portfolio for animal health includes a wide range of products, such as vaccines and nutritional supplements, designed to improve livestock productivity. In the human health sector, the company is a key manufacturer of antibiotics like Fosfomycin Trometamol and also develops niche generic medicines and innovative feed additives through subsidiaries such as Zoleant Pharmaceuticals and Veterinarski Zavod Subotica.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Labiana S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Labiana S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Labiana S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.